Anand Bhaskar
Officer at REATA PHARMACEUTICALS INC
- Sold, on record
- $554k
- Dollars the filings state
- Form 4 sales
- 6
- Latest Sep 5, 2023
- Form 144 notices
- 6
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- REATA PHARMACEUTICALS INCOfficer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale REATA PHARMACEUTICALS INCNo planMay 16, 2023 2023
Sold 1,086 shares at $85.37 ($93k)
Anand Bhaskar, SVP, Chief Accounting Officer
No 10b5-1 planSold 4.1% of holdings ($2.3M position)25,679 shares leftFollows a Form 144Filing
- 2 Form 144 notice REATA PHARMACEUTICALS INCNoticeJun 14, 2023 +29 days
Filed to sell 2,343 shares ($239k)
Anand Bhaskar, Officer
No 10b5-1 plan2.9x usual sizeFiling
- 3 Form 4 sale REATA PHARMACEUTICALS INCNo planJun 14, 2023 same day
Sold 2,343 shares at $102.11 ($239k)
Anand Bhaskar, SVP, Chief Accounting Officer
No 10b5-1 planSold 8.6% of holdings ($2.8M position)24,898 shares left2.9x usual sizeFollows a Form 144Filing
- 4 Form 144 notice REATA PHARMACEUTICALS INCNoticeAug 15, 2023 +62 days
Filed to sell 193 shares ($33k)
Anand Bhaskar, Officer
No 10b5-1 plan0.2x usual sizeFiling
- 5 Form 144 notice REATA PHARMACEUTICALS INCNoticeAug 16, 2023 +1 day
Filed to sell 210 shares ($35k)
Anand Bhaskar, Officer
No 10b5-1 plan0.2x usual sizeFiling
- 6 Form 4 sale REATA PHARMACEUTICALS INCNo planAug 16, 2023 same day
Sold 403 shares at $168.73 ($68k)
Anand Bhaskar, SVP, Chief Accounting Officer
No 10b5-1 planSold 1.6% of holdings ($4.2M position)24,495 shares left0.4x usual sizeFollows a Form 144Filing
- 7 Form 144 notice REATA PHARMACEUTICALS INCNoticeSep 5, 2023 +20 days
Filed to sell 406 shares ($69k)
Anand Bhaskar, Officer
No 10b5-1 plan0.5x usual sizeFiling
- 8 Form 4 sale REATA PHARMACEUTICALS INCNo planSep 5, 2023 same day
Sold 406 shares at $169.20 ($69k)
Anand Bhaskar, SVP, Chief Accounting Officer
No 10b5-1 planSold 1.7% of holdings ($4.1M position)24,089 shares left0.5x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (12)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Sep 5, 2023 | Sep 7, 2023 | REATA PHARMACEUTICALS INC | SVP, Chief Accounting Officer | Form 4 sale | 406 | $69k | 1.7% | No plan | SEC |
| Sep 5, 2023 | Sep 5, 2023 | REATA PHARMACEUTICALS INC | Officer | Form 144 notice | 406 | $69k | Notice | SEC | |
| Aug 16, 2023 | Aug 17, 2023 | REATA PHARMACEUTICALS INC | SVP, Chief Accounting Officer | Form 4 sale | 403 | $68k | 1.6% | No plan | SEC |
| Aug 16, 2023 | Aug 16, 2023 | REATA PHARMACEUTICALS INC | Officer | Form 144 notice | 210 | $35k | Notice | SEC | |
| Aug 15, 2023 | Aug 15, 2023 | REATA PHARMACEUTICALS INC | Officer | Form 144 notice | 193 | $33k | Notice | SEC | |
| Jun 14, 2023 | Jun 16, 2023 | REATA PHARMACEUTICALS INC | SVP, Chief Accounting Officer | Form 4 sale | 2,343 | $239k | 8.6% | No plan | SEC |
| Jun 14, 2023 | Jun 14, 2023 | REATA PHARMACEUTICALS INC | Officer | Form 144 notice | 2,343 | $239k | Notice | SEC | |
| May 16, 2023 | May 17, 2023 | REATA PHARMACEUTICALS INC | SVP, Chief Accounting Officer | Form 4 sale | 1,086 | $93k | 4.1% | No plan | SEC |
| May 16, 2023 | May 16, 2023 | REATA PHARMACEUTICALS INC | Officer | Form 144 notice | 136 | $11k | Notice | SEC | |
| May 15, 2023 | May 15, 2023 | REATA PHARMACEUTICALS INC | Officer | Form 144 notice | 950 | $82k | Notice | SEC | |
| Mar 7, 2023 | Mar 8, 2023 | REATA PHARMACEUTICALS INC | SVP, Chief Accounting Officer | Form 4 sale | 165 | $14k | 0.6% | Plan not stated | SEC |
| Mar 3, 2023 | Mar 6, 2023 | REATA PHARMACEUTICALS INC | SVP, Chief Accounting Officer | Form 4 sale | 820 | $72k | 3.0% | Plan not stated | SEC |